110 related articles for article (PubMed ID: 3524829)
1. Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Gockerman JP; Bartolucci AA; Nelson MO; Silberman H; Velez-Garcia E; Stein R
Cancer Treat Rep; 1986 Jun; 70(6):801-2. PubMed ID: 3524829
[No Abstract] [Full Text] [Related]
2. Phase II study of etoposide for carcinoma of the prostate.
Walther PJ; Williams SD; Troner M; Greco FA; Birch R; Einhorn LH
Cancer Treat Rep; 1986 Jun; 70(6):771-2. PubMed ID: 3524825
[TBL] [Abstract][Full Text] [Related]
3. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Gockerman JP; Silberman H; Bartolucci AA
Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970
[No Abstract] [Full Text] [Related]
4. Phase I trial of a new form of an oral administration of VP-16-213.
Lau ME; Hansen HH; Nissen NI; Pedersen H
Cancer Treat Rep; 1979 Mar; 63(3):485-7. PubMed ID: 371801
[TBL] [Abstract][Full Text] [Related]
5. Phase II clinical trial of VP-16-213 in ovarian cancer.
Maskens AP; Armand JP; Lacave AJ; De Jager RL; Hansen HH; Wolff JP
Cancer Treat Rep; 1981; 65(3-4):329-30. PubMed ID: 7016320
[No Abstract] [Full Text] [Related]
6. Phase II trial of etoposide in advanced prostate cancer.
Trump DL; Loprinzi CL
Cancer Treat Rep; 1984 Sep; 68(9):1195-6. PubMed ID: 6478456
[No Abstract] [Full Text] [Related]
7. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
[No Abstract] [Full Text] [Related]
8. Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Delgado G
Cancer Treat Rep; 1982 Aug; 66(8):1669-71. PubMed ID: 7105059
[No Abstract] [Full Text] [Related]
9. Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
Kelsen DP; Magill GB; Cheng E; Dukeman M; Sordillo P; Heelan R; Yagoda A
Cancer Treat Rep; 1983 May; 67(5):509-10. PubMed ID: 6850667
[No Abstract] [Full Text] [Related]
10. Weekly mitoxantrone therapy for refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Esseesse I; Bartolucci AA; Gams RA; Silberman H; Velez-Garcia E; Cohen HJ; Omura GA
Cancer Treat Rep; 1986 May; 70(5):669-70. PubMed ID: 3708615
[No Abstract] [Full Text] [Related]
11. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
[TBL] [Abstract][Full Text] [Related]
12. Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group.
Muss H; Bundy BN; DiSaia PJ; Twiggs LB
Cancer Treat Rep; 1986 Oct; 70(10):1231-2. PubMed ID: 3530450
[No Abstract] [Full Text] [Related]
13. Etoposide plus idarubicin and prednisone in refractory or relapsed multiple myeloma. A phase II study.
Capnist G; Chisesi T
Haematologica; 1988; 73(5):431-2. PubMed ID: 3143647
[No Abstract] [Full Text] [Related]
14. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
Yoshida T; Nakanishi J; Ito K; Kobayashi S; Ohtake S; Nakamura S; Hattori K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of etoposide in the treatment of esophageal carcinoma.
Coonley CJ; Bains M; Heelan R; Dukeman M; Kelsen DP
Cancer Treat Rep; 1983 Apr; 67(4):397-8. PubMed ID: 6850656
[No Abstract] [Full Text] [Related]
16. [Phase II study of etoposide (VP-16-213) in genitourinary tumors. VP-16-213 Genitourinary Study Group].
Suzuki K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2772-9. PubMed ID: 3753024
[TBL] [Abstract][Full Text] [Related]
17. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
Kimura K; Yamada K; Yoshida T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of etoposide, vincristine, and high-dose cisplatin in advanced non-small cell lung cancer.
Bertrand M; Multhauf P; Presant C; Rappaport D; Blayney DW; Carr BI; Cecchi G; Doroshow JH; Emont E; Goldberg D
Cancer Treat Rep; 1985 Nov; 69(11):1335-6. PubMed ID: 4092199
[No Abstract] [Full Text] [Related]
19. [Phase II study of etoposide in malignant lymphoma].
Onoshi T; Hayashi K; Ueoka H; Nishihara R; Toyota K
Gan To Kagaku Ryoho; 1984 Apr; 11(4):952-3. PubMed ID: 6721509
[No Abstract] [Full Text] [Related]
20. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
[No Abstract] [Full Text] [Related]
[Next] [New Search]
